1. Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry. Issue 10 (25th May 2017) Authors: Welzel, T. M.; Hinrichsen, H.; Sarrazin, C.; Buggisch, P.; Baumgarten, A.; Christensen, S.; Berg, T.; Mauss, S.; Teuber, G.; Stein, K.; Deterding, K.; van Bömmel, F.; Heyne, R.; John, C.; Zimmermann, T.; Lutz, T.; Schott, E.; Hettinger, J.; Kleine, H.; König, B. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 10(2017) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗